Synthesis, modeling and biological activity of new zinc(II) hydroxamates against streptococcus pneumoniae

[1]  F. El-Essawy,et al.  Synthesis, spectral, thermal and antimicrobial studies on cobalt(II), nickel(II), copper(II), zinc(II) and palladium(II) complexes containing thiosemicarbazone ligand , 2018 .

[2]  G. Murtaza,et al.  Synthesis, spectroscopic characterization, X-ray diffraction studies and in-vitro antibacterial activities of diorganotin(IV) derivatives with N-methyl-4-bromobenzohydroxamic acid , 2018 .

[3]  G. Mohamed,et al.  Synthesis, spectral, thermal and biological studies of mixed ligand complexes with newly prepared Schiff base and 1,10-phenanthroline ligands , 2017 .

[4]  M. Kose,et al.  New fluorescent azo-Schiff base Cu(II) and Zn(II) metal chelates; spectral, structural, electrochemical, photoluminescence and computational studies , 2017 .

[5]  R. Arora,et al.  Theoretical study of the molecular structure and intramolecular proton transfer in benzohydroxamic acid , 2017 .

[6]  Heba A. Hassan,et al.  Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives. , 2017, Bioorganic chemistry.

[7]  A. Gündüzalp,et al.  Structural, physicochemical characterization, theoretical studies of carboxamides and their Cu(II), Zn(II) complexes having antibacterial activities against E. coli , 2017 .

[8]  F. Yılmaz,et al.  Synthesis and characterization of two new hydroxamic acids derivatives and their metal complexes. An investigation on the keto/enol, E/Z and hydroxamate/hydroximate forms , 2017 .

[9]  S. Franzblau,et al.  Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis. , 2015, Bioorganic & medicinal chemistry letters.

[10]  D. Ugwuja,et al.  Synthesis and Biological Applications of Hydroxamates , 2014 .

[11]  B. Han,et al.  Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents. , 2013, European journal of medicinal chemistry.

[12]  Hai‐Liang Zhu,et al.  Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. , 2013, European journal of medicinal chemistry.

[13]  K. Nolan,et al.  Hydroxamic Acids: An Important Class of Metalloenzyme Inhibitors , 2013 .

[14]  Laichun Lu,et al.  Synthesis and preliminary antibacterial evaluation of hydroxamic acid and N-formyl hydroxylamine derivatives bearing oxazole ring , 2012, Medicinal Chemistry Research.

[15]  James J. P. Stewart,et al.  Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters , 2012, Journal of Molecular Modeling.

[16]  A. Al‐Saadi.  Conformational analysis and vibrational assignments of benzohydroxamic acid and benzohydrazide , 2012 .

[17]  K. Zeth.  Dps biomineralizing proteins: multifunctional architects of nature. , 2012, The Biochemical journal.

[18]  N. Sultana,et al.  Synthesis, spectroscopic, and biological evaluation of some levofloxacin metal complexes , 2012, Medicinal Chemistry Research.

[19]  Hua-Jun Luo,et al.  Docking study on trametenolic acid B as a α-glucosidase inhibitor , 2012, Medicinal Chemistry Research.

[20]  Abdullah Mohamed Asiri,et al.  Synthesis, molecular conformation, vibrational and electronic transition, isometric chemical shift, polarizability and hyperpolarizability analysis of 3-(4-methoxy-phenyl)-2-(4-nitro-phenyl)-acrylonitrile: a combined experimental and theoretical analysis. , 2011, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[21]  M. Arivazhagan,et al.  Vibrational spectroscopic, first-order hyperpolarizability and HOMO, LUMO studies of 1,2-dichloro-4-nitrobenzene based on Hartree-Fock and DFT calculations. , 2011, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[22]  P. Buglyó,et al.  Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes. , 2011, Journal of inorganic biochemistry.

[23]  Fushi Zhang,et al.  3D-QSAR and molecular docking studies of hydroxamic acids as peptide deformylase inhibitors , 2011, Medicinal Chemistry Research.

[24]  Elizabeth Yuriev,et al.  Challenges and advances in computational docking: 2009 in review , 2011, Journal of molecular recognition : JMR.

[25]  Abdul-Rahman Allouche,et al.  Gabedit—A graphical user interface for computational chemistry softwares , 2011, J. Comput. Chem..

[26]  E. Csapó,et al.  Syntheses and characterization of Cu2+, Ni2+ and Zn2+ binding capability of histidinehydroxamic acid derivatives , 2010 .

[27]  N. Colthup,et al.  Infrared and Raman Spectroscopy Study of Alkyl Hydroxamic Acid and Alkyl Hydroxamate Isomers , 2006, Applied spectroscopy.

[28]  F. Portaels,et al.  Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.

[29]  S. Chandler,et al.  Antibacterial Activities and Characterization of Novel Inhibitors of LpxC , 2002, Antimicrobial Agents and Chemotherapy.

[30]  Nam-Chul Ha,et al.  Supramolecular assembly and acid resistance of Helicobacter pylori urease , 2001, Nature Structural Biology.

[31]  W. Haase,et al.  HYDROXAMATE-BRIDGED DINUCLEAR NICKEL COMPLEXES AS MODELS FOR UREASE INHIBITION , 1998 .

[32]  B. Chatterjee.  Donor properties of hydroxamic acids , 1978 .